ArticleACS omega2023
Conductometric Flexible CuO-Based Sweat-Loss Monitoring Sensor for Future Wearable Technology in Healthcare.
Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Healthcare tracking supports early diagnosis of illnesses, real-time tracking of the impacts of therapy and treatment, and tracking of cases of human health. Based on this, real-time tracking of sweat loss provides an easy, convenient, and noninvasive approach to the early diagnosis of physical illness in individuals. To date, copper oxide (CuO) as a nanostructured semiconductor metal-oxide is regarded as a hopefully p-type sensing material. The corresponding sweat rate monitoring systems were fabricated using a repeatable and cost-effective SILAR system using a cellulose acetate-based organic substrate. To provide a practical application, we investigated the working efficiency of Al:CuO under room conditions since most clinical and healthcare industries operate under ambient temperature. Fabricated flexible devices immediately respond to the implementation of the sweat solution and reach a steady-state value in a short time. It can be obtained from experimental results that the sweat-loss monitoring performances of CuO-based devices can be enhanced by employing Al-doping. The increment in the sensing efficacy was interpreted in terms of structural and morphological characterization and electrical data. Our designed flexible thin film-based system can be used in conjunction with a customized wearable, healthcare industry integrated, low-cost fabrication source.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.